A discovery-stage company founded 10 years ago and focused on developing a PINK1 activator for Parkinson’s disease and other indications is now under the umbrella of Abbvie Inc. through an acquisition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback